Cheng‐Cheng Deng

747 total citations · 1 hit paper
20 papers, 501 citations indexed

About

Cheng‐Cheng Deng is a scholar working on Molecular Biology, Dermatology and Rehabilitation. According to data from OpenAlex, Cheng‐Cheng Deng has authored 20 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Dermatology and 6 papers in Rehabilitation. Recurrent topics in Cheng‐Cheng Deng's work include Dermatologic Treatments and Research (9 papers), Wound Healing and Treatments (6 papers) and RNA modifications and cancer (4 papers). Cheng‐Cheng Deng is often cited by papers focused on Dermatologic Treatments and Research (9 papers), Wound Healing and Treatments (6 papers) and RNA modifications and cancer (4 papers). Cheng‐Cheng Deng collaborates with scholars based in China and Brunei. Cheng‐Cheng Deng's co-authors include Bin Yang, Zhili Rong, Dingheng Zhu, Jingjing Gu, Yingping Xu, Lixue Zhang, Qing Cheng, Dong Wang, Yongfei Hu and Yi-Xin Zeng and has published in prestigious journals such as Nature Communications, Cancer Research and Frontiers in Immunology.

In The Last Decade

Cheng‐Cheng Deng

19 papers receiving 498 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases

2021 280 citations Cheng‐Cheng Deng, Yongfei Hu et al. Nature Communications profile →

Peers

Countries citing papers authored by Cheng‐Cheng Deng

Since Specialization

Citations

This map shows the geographic impact of Cheng‐Cheng Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Cheng Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Cheng Deng more than expected).

Fields of papers citing papers by Cheng‐Cheng Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Cheng Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Cheng Deng. The network helps show where Cheng‐Cheng Deng may publish in the future.

Co-authorship network of co-authors of Cheng‐Cheng Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Cheng Deng. A scholar is included among the top collaborators of Cheng‐Cheng Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Cheng Deng. Cheng‐Cheng Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lactate Promotes Collagen Expression, Proliferation, and Migration through H3K18 Lactylation–Dependent Stimulation of LTBP3/TGF-β1 Axis in Keloid Fibroblasts 2025 ·Journal of Investigative Dermatology ·Jingjing Gu, Cheng‐Cheng Deng, Qing An, Dingheng Zhu, (unknown), (unknown), Zhengyang Zhou, Zhili Rong, Bin Yang	2
2	ASGPR-targeted micelles co-delivering lenvatinib and COP1 siRNA for hepatocellular carcinoma via dual-targeting 2025 ·European Journal of Pharmaceutical Sciences ·(unknown), Qian Li, Cheng‐Cheng Deng, Feng Yang, Zhi Xie, Wenyan Jia, (unknown)	0
3	Single-cell RNA-seq reveals immune cell heterogeneity and increased Th17 cells in human fibrotic skin diseases 2025 ·Frontiers in Immunology ·Cheng‐Cheng Deng, (unknown), Yan Zhang, (unknown), Xuan Wang, (unknown), Lihong Yao, Dingheng Zhu, Bin Yang	4
4	Inhibition of Ubiquitin C‐Terminal Hydrolase L1 Facilitates Cutaneous Wound Healing via Activating TGF ‐β/Smad Signalling Pathway in Fibroblasts 2024 ·Experimental Dermatology ·(unknown), (unknown), Qing An, (unknown), Wenyue Zheng, Litian Zhang, Jingjing Gu, Cheng‐Cheng Deng, (unknown)	3
5	CELSR3 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment 2024 ·European Archives of Oto-Rhino-Laryngology ·(unknown), (unknown), (unknown), Shiping Hu, (unknown), Xinmei Huang, Qiang Xie, Cheng‐Cheng Deng	1
6	SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment 2023 ·European Archives of Oto-Rhino-Laryngology ·Zhongbiao Wu, (unknown), (unknown), (unknown), (unknown), Qiang Xie, Cheng‐Cheng Deng, Xinmei Huang, (unknown)	3
7	Relief of Extracellular Matrix Deposition Repression by Downregulation of IRF1-Mediated TWEAK/Fn14 Signaling in Keloids 2023 ·Journal of Investigative Dermatology ·Jingjing Gu, Cheng‐Cheng Deng, (unknown), Jun Liu, Dingheng Zhu, Qing Cheng, Zhili Rong, Bin Yang	7
8	Isolation, Culture, and Characterization of Primary Dermal Fibroblasts from Human Keloid Tissue 2023 ·Journal of Visualized Experiments ·(unknown), Yue Zhang, Huihui Pan, (unknown), Cheng‐Cheng Deng, Bin Yang	6
9	An Open-Label, Uncontrolled, Single-Arm Clinical Trial of Tofacitinib, an Oral JAK1 and JAK3 Kinase Inhibitor, in Chinese Patients with Keloid 2023 ·Dermatology ·(unknown), (unknown), (unknown), Dingheng Zhu, (unknown), Cheng‐Cheng Deng, Bin Yang	6
10	Risk single-nucleotide polymorphism-mediated enhancer–promoter interaction drives keloids through long noncoding RNA down expressed in keloids 2022 ·British Journal of Dermatology ·Cheng‐Cheng Deng, Lixue Zhang, (unknown), Dingheng Zhu, Qing Cheng, Shufeng Ma, Zhili Rong, Bin Yang	9
11	TSP1 promotes fibroblast proliferation and extracellular matrix deposition via the IL6/JAK2/STAT3 signalling pathway in keloids 2022 ·Experimental Dermatology ·(unknown), Jingjing Gu, (unknown), Wenyue Zheng, (unknown), (unknown), Cheng‐Cheng Deng, Bin Yang	14
12	LncRNA CCAT1 facilitates the proliferation, invasion and migration of human laryngeal squamous cell carcinoma cells via the miR-218-5p/BMI1 2022 ·PeerJ ·Jing Hong, (unknown), (unknown), (unknown), (unknown), Cheng‐Cheng Deng, Tao Bo, (unknown), (unknown)	4
13	Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases breakdown → 2021 ·Nature Communications ·Cheng‐Cheng Deng, Yongfei Hu, Dingheng Zhu, Qing Cheng, Jingjing Gu, (unknown), Lixue Zhang, Yingping Xu, Dong Wang, Zhili Rong, Bin Yang	280
14	TRAF4 Promotes Fibroblast Proliferation in Keloids by Destabilizing p53 via Interacting with the Deubiquitinase USP10 2019 ·Journal of Investigative Dermatology ·Cheng‐Cheng Deng, Dingheng Zhu, Yongjun Chen, (unknown), (unknown), (unknown), Ping Lü, Yaohua Xue, Yingping Xu, Bin Yang, Zhili Rong	38
15	Clinical and genetic features of Chinese patients with lichen and macular primary localized cutaneous amyloidosis 2019 ·Clinical and Experimental Dermatology ·Ping Lü, (unknown), Zhili Rong, Christina H. Fang, Cheng‐Cheng Deng, Lianghua Bin, Bin Yang	11
16	Loss of MED12 Induces Tumor Dormancy in Human Epithelial Ovarian Cancer via Downregulation of EGFR 2018 ·Cancer Research ·(unknown), Cheng‐Cheng Deng, Xiao‐Dong Su, Fang Wang, Zhen Chen, (unknown), Shao-Bo Liang, Jihong Liu, Liwu Fu	23
17	TNFRSF19 Inhibits TGFβ Signaling through Interaction with TGFβ Receptor Type I to Promote Tumorigenesis 2018 ·Cancer Research ·Cheng‐Cheng Deng, (unknown), (unknown), (unknown), Yuchen Zhang, Hao-Jiong Zhang, Miao Xu, Qi-Sheng Feng, Jin‐Xin Bei, Yi-Xin Zeng, Lin Feng	34
18	Abstract 5503: Loss of MED12 induces tumor dormancy in human ovarian cancer 2018 ·Cancer Research ·Xiaolin Luo, Cheng‐Cheng Deng, Jihong Liu, Liwu Fu	1
19	Unconjugated Bilirubin Is a Novel Prognostic Biomarker for Nasopharyngeal Carcinoma and Inhibits Its Metastasis via Antioxidation Activity 2015 ·Cancer Prevention Research ·Cheng‐Cheng Deng, Miao Xu, Jing Li, (unknown), (unknown), Rou Jiang, Meng-Xia Zhang, (unknown), (unknown), Xiong Zou, Rui You, Li-Zhen Chen, Qi-Sheng Feng, Jin‐Xin Bei, Ming‐Yuan Chen, Yi-Xin Zeng	11
20	Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma 2013 ·The International Journal of Biochemistry & Cell Biology ·Cheng‐Cheng Deng, Yi Liang, (unknown), (unknown), (unknown), Li-Zhen Chen, Qi-Sheng Feng, Jin‐Xin Bei, Yi-Xin Zeng	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact